Yunxiu Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yunxiu Wang has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Zhaowei Gu
Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, PR China
7 shared publications - Zhiwei Cao
Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, PR China
3 shared publications - Jiani Li
Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang, People’s Republic of China
2 shared publications - Jing Yang
Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang, People’s Republic of China
2 shared publications Meng Wang
Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, PR China
2 shared publications- Meng Wang
Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, PR China
2 shared publications
Latest Publications
- 28 July 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 187, 117192
Dual role of macrophage heterogeneity in allergic inflammation: from mechanism to targeted therapy
- 28 July 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 187, 117192
Dual role of macrophage heterogeneity in allergic inflammation: from mechanism to targeted therapy
- 6 July 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 186, 117112
Macrophage autophagy in allergic diseases: Regulatory mechanisms, immune crosstalk, and therapeutic implications
- 6 July 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 186, 117112
Macrophage autophagy in allergic diseases: Regulatory mechanisms, immune crosstalk, and therapeutic implications
- Open Access
- 10 April 2026
- Published by Frontiers Media SA in Frontiers in Allergy
- Vol. 7, 1806555
The relationship between allergic rhinitis and sleep disorders and mental health
Allergic Rhinitis (AR) is a highly prevalent IgE-mediated chronic inflammatory disease of the nasal mucosa worldwide. Its incidence is continuously increasing and has become one of the important chronic diseases affecting public health. Recent studies have gradually revealed that AR not only presents with local symptoms such as nasal congestion, runny nose, sneezing, and nasal itching, but is also closely related to a wide range of physical and mental health problems, especially mental and psychological disorders (such as anxiety and depression) and decreased sleep quality. There is a complex two-way or even circular interaction between these three factors. This article systematically reviews the epidemiological characteristics and pathophysiological mechanisms of AR, and focuses on exploring the association pathways and potential mechanisms between AR and mental health as well as sleep disorders, including neuroimmune regulation (such as inflammatory mediators, HPA axis function), psychological and behavioral factors, and social function impairment. Based on this, the article further summarizes the assessment tools and multimodal intervention strategies for mental and psychological problems and sleep disorders in AR patients, covering drug treatment, psychotherapy, sleep hygiene education, and comprehensive health management, etc. This article integrates current evidence and provides a theoretical framework for a comprehensive understanding of the multi-dimensional impact of AR, and offers references for comprehensive assessment and individualized intervention in clinical practice.
- 10 April 2026
- Published by Frontiers Media SA in Frontiers in Allergy
- Vol. 7, 1806555
Open AccessThe relationship between allergic rhinitis and sleep disorders and mental health
Allergic Rhinitis (AR) is a highly prevalent IgE-mediated chronic inflammatory disease of the nasal mucosa worldwide. Its incidence is continuously increasing and has become one of the important chronic diseases affecting public health. Recent studies have gradually revealed that AR not only presents with local symptoms such as nasal congestion, runny nose, sneezing, and nasal itching, but is also closely related to a wide range of physical and mental health problems, especially mental and psychological disorders (such as anxiety and depression) and decreased sleep quality. There is a complex two-way or even circular interaction between these three factors. This article systematically reviews the epidemiological characteristics and pathophysiological mechanisms of AR, and focuses on exploring the association pathways and potential mechanisms between AR and mental health as well as sleep disorders, including neuroimmune regulation (such as inflammatory mediators, HPA axis function), psychological and behavioral factors, and social function impairment. Based on this, the article further summarizes the assessment tools and multimodal intervention strategies for mental and psychological problems and sleep disorders in AR patients, covering drug treatment, psychotherapy, sleep hygiene education, and comprehensive health management, etc. This article integrates current evidence and provides a theoretical framework for a comprehensive understanding of the multi-dimensional impact of AR, and offers references for comprehensive assessment and individualized intervention in clinical practice.
- 5 May 2025
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 68 (1) , 1-14
Mechanisms and Therapeutic Implications of EZH2 in Nasal Diseases
Enhancer of zeste homolog 2 (EZH2), a protein encoded by the EZH2 gene, is a crucial subunit in polycomb repressive complex 2. EZH2 controls the transcription of genes critical for cell proliferation, differentiation, amplification, and function through both methylated and unmethylated functions. EZH2 is considered to be a transcriptional suppressor protein when it controls histone methylation. Its dysregulation is related to a variety of cancers, with significant evidence showing its role in prostate cancer and breast cancer. EZH2 is also thought to be involved in the differentiation and function of immune cells. Ongoing research on EZH2 has revealed the correlation between inflammatory nasal diseases, the occurrence and development of nasal sinus tumors, and EZH2. This article aimed to review the research progress on the role of EZH2 in nasal diseases and explore the possibility of future EZH2-targeted therapies for nasal diseases.
- 5 May 2025
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 68 (1) , 1-14
Mechanisms and Therapeutic Implications of EZH2 in Nasal Diseases
Enhancer of zeste homolog 2 (EZH2), a protein encoded by the EZH2 gene, is a crucial subunit in polycomb repressive complex 2. EZH2 controls the transcription of genes critical for cell proliferation, differentiation, amplification, and function through both methylated and unmethylated functions. EZH2 is considered to be a transcriptional suppressor protein when it controls histone methylation. Its dysregulation is related to a variety of cancers, with significant evidence showing its role in prostate cancer and breast cancer. EZH2 is also thought to be involved in the differentiation and function of immune cells. Ongoing research on EZH2 has revealed the correlation between inflammatory nasal diseases, the occurrence and development of nasal sinus tumors, and EZH2. This article aimed to review the research progress on the role of EZH2 in nasal diseases and explore the possibility of future EZH2-targeted therapies for nasal diseases.
- Open Access
- 1 November 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 181, 117655
The role and mechanism of extracellular traps in chronic rhinosinusitis
- 1 November 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 181, 117655
Open AccessThe role and mechanism of extracellular traps in chronic rhinosinusitis
- Open Access
- 24 June 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 177, 117019
Effect of IL-9 neutralising antibody on pyroptosis via SGK1/NF-κB/NLRP3/GSDMD in allergic rhinitis mice
- 24 June 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 177, 117019
Open AccessEffect of IL-9 neutralising antibody on pyroptosis via SGK1/NF-κB/NLRP3/GSDMD in allergic rhinitis mice
- Open Access
- 21 July 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 165, 115203
Understanding the role of NLRP3-mediated pyroptosis in allergic rhinitis: A review
- 21 July 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 165, 115203
Open AccessUnderstanding the role of NLRP3-mediated pyroptosis in allergic rhinitis: A review